Caissa Capital Management ltd. is 10% Owner at Avalo Therapeutics, Inc. (AVTX). They have made 13 open-market trades across 1 company since 2023, most recently 2023-06-26.
CIK 0001929354
13 open-market purchases totalling $1.7M since 2023, never a sale. Across 13 scored buys the stock is down 94.4% at ninety days, and 100.9 points behind the S&P over the same stretch.
13 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| AVTX | 1,425,700 | $16.1M |
Shares reported on the most recent Form 4, priced at the 2023-06-20 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 54% | 38% | 0% |
| Avg Move | -9.3% | -22.7% | -94.4% |
| Alpha | -10.6% | -25.9% | -100.9% |
| Scored | 13 | 13 | 13 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AVTX | BUY | 2023-06-26 | 2023-06-27 | $0.64 | $1.0M | -22.0% | -55.9% | -65.1% |
| AVTX | BUY | 2023-06-15 | 2023-06-20 | $3.87 | $32K | -91.1% | -92.1% | -96.9% |
| AVTX | BUY | 2023-06-12 | 2023-06-14 | $3.77 | $64K | -86.0% | -89.2% | -96.0% |
| AVTX | BUY | 2023-06-07 | 2023-06-09 | $3.91 | $56K | +3.9% | -91.2% | -97.7% |
| AVTX | BUY | 2023-05-31 | 2023-06-02 | $2.87 | $2K | +5.6% | -87.8% | -96.5% |
| AVTX | BUY | 2023-05-25 | 2023-05-30 | $2.80 | $7K | +39.1% | -87.2% | -96.5% |
| AVTX | BUY | 2023-05-24 | 2023-05-24 | $2.98 | $27K | +4.2% | +52.9% | -96.9% |
| AVTX | BUY | 2023-05-18 | 2023-05-22 | $3.36 | $89K | -3.7% | +33.3% | -96.3% |
| AVTX | BUY | 2023-05-12 | 2023-05-16 | $2.52 | $11K | +9.8% | +36.4% | -95.3% |
| AVTX | BUY | 2023-05-04 | 2023-05-08 | $2.77 | $69K | +26.5% | +49.6% | -93.9% |
| AVTX | BUY | 2023-04-25 | 2023-04-27 | $2.99 | $22K | -11.0% | -1.4% | -92.1% |
| AVTX | BUY | 2023-04-20 | 2023-04-24 | $3.07 | $54K | -10.2% | -8.0% | -91.9% |
| AVTX | BUY | 2023-04-17 | 2023-04-18 | $2.95 | $74K | +1.4% | +14.6% | -88.0% |
| AVTX | BUY | 2023-04-10 | 2023-04-11 | $2.44 | $214K | -9.5% | -25.2% | -88.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.